MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Relationship between cognitive performance and mobility in Parkinson’s disease

    A. Amara, K. Wood, A. Joop, R. Memon, J. Pilkington, M. Bamman, C. Hurt (Birmingham, AL, USA)

    Objective: Investigate relationship between cognitive performance and mobility in persons with Parkinson’s disease (PD). Background: Persons with PD experience both motor and non-motor symptoms. Two…
  • 2019 International Congress

    Impaired fonction of mirror neurons and the role of levodopa in PD patients

    T. Danaila, P. Jaulent, C. Laurencin, J. Xie, H. Klinger, P. Krolak-Salmon, S. Thobois (Lyon, France)

    Objective: Study of the emotional mirroring and its modulation by levodopa treatment in fluctuating PD patients with no significant cognitive burden as assessed by regular…
  • 2019 International Congress

    Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

    C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)

    Objective: The present study aims to assess cognitive function in a rat model of mutated alpha-synuclein overexpression in order to determine whether this model can…
  • 2019 International Congress

    Clinical, motor and global cognition in patients with in early stages of Parkinson disease

    J. Orozco, J. Valderrama, Y. Castaño, J. Arango, A. Navarro, B. Muñoz (Cali, Colombia)

    Objective: To explore if balance and freezing of gait correlate with global cognition in patients with Parkinson disease in early stages. Background: Early alterations in…
  • 2019 International Congress

    Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

    Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…
  • 2019 International Congress

    Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease

    A. Gonçalves, A. Mendes, N. Vila-Chã, I. Moreira, S. Cavaco (Porto, Portugal)

    Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…
  • 2019 International Congress

    Increased fractional anisotropy in precuneus in Parkinson’s disease without mild cognitive impairment – a diffusion tensor imaging study

    A. Nagano-Saito, J. Houde, C. Bedetti, M. Côté, O. Monchi (Montreal, QC, Canada)

    Objective: Using diffusion tensor imaging (DTI) data of healthy volunteers and patients with Parkinson’s disease (PD) with and without mild cognitive impairment (MCI),  we search…
  • 2019 International Congress

    Dentatorubral-Pallidoluysian Atrophy outside of Asia: A case report of the first Austrian family harbouring this rare mutation

    M. Amprosi, W. Nachbauer, E. Indelicato, A. Eigentler, G. Puttinger, J. Gusenleitner, T. von Oertzen, S. Boesch (Innsbruck, Austria)

    Objective: To report clinical features of the first Austrian family with Dentatorubral-Pallidoluysian Atrophy (DRPLA). Background: DRPLA is a progressive disorder with an autosomal-dominant mode of…
  • 2019 International Congress

    Compensatory Amygdala Activity during motor timing and selection in PD

    SPD. Allahdadian, H. Rafipoor, E. Yargholi, M. Mirian, MJM. Mckeown (Vancouver, BC, Canada)

    Objective: To investigate the role of the amygdala in motor program selection and timing in Parkinson disease. Background: PD is characterized by considerable heterogeneity, which…
  • 2019 International Congress

    Parkinson Disease Clinical Subtypes Predict Dementia and Mortality Risk

    P. Myers, M. Campbell, A. Weigand, N. Cairns, J. Jackson, C. Lessov-Schlaggar, J. Perlmutter (St. Louis, MO, USA)

    Objective: To identify PD clinical subtypes based on patterns of motor, cognitive, and psychiatric symptoms; to assess the clinical utility of each subtype in predicting…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley